Institutional Investing

Recent SEC filings link powerhouse investor Citadel to streaming upstart FreeCast. But as we peel back the layers, a story of high-risk, high-reward emerges.

After a decade-long retreat, Gulf institutions are set to deploy $20 billion into US real estate, targeting rentals and demanding unprecedented control.

A major Florida acquisition reveals a sophisticated new model for senior housing, blending private equity with data-driven operations to meet a demographic boom.

Fintech platform Premialab is poaching top talent from finance giants. Its latest hire reveals a bold strategy to dominate the complex world of quant data.

Amid a tough fundraising climate, Hamilton Lane's record fund close reveals a key strategy for 2026: the enduring power of the middle-market buyout.

Relmada Therapeutics joins the Russell 2000, a key validation that opens doors to new capital. But can its high-stakes pipeline deliver on this promise?

As private credit swells to a $1.5 trillion industry, StoneCastle Securities appoints a veteran analyst to navigate its growing complexity and opportunity.

As institutional capital seeks refuge from market volatility, Stable Asset Management's $100M backing of Zenzic Capital signals a major bet on specialist credit.

Alight's 1-for-20 reverse split aims to save its NYSE listing. Is this a savvy strategic reset or a temporary fix for a stock facing deeper challenges?

SOLAI Limited's 1-for-7 reverse split is a necessary move to avoid NYSE delisting, but is it a sign of distress or a strategic reset for its AI future?

Set to join the Russell 3000, Starfighters Space and its unique F-104 fleet bring Wall Street's focus to a new class of aerospace infrastructure.

VFF's balance sheet didn't need the cash, so why take it? A deep dive into a strategic capital raise that's less about liquidity and more about legitimacy.

As it marks 50 years, Alaska's $86B Permanent Fund adjusts its investment mix, moving away from private equity amid changing market realities.

In a landmark move, FINRA has authorized Ohanae Securities to custody and clear crypto asset securities, paving the way for a new era of regulated digital markets.

Cannabis giant Curaleaf is rolling the dice with a reverse stock split, aiming for a coveted spot on a major U.S. exchange ahead of federal rescheduling.

The Web3 data provider is partnering with top auditors and adopting ISO standards, aiming to attract institutional capital to Southeast Asia's crypto market.

Digital asset giant BIT gains crucial regulatory approval in the British Virgin Islands, a major step in building a compliant global network for pro investors.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.